Search research articles
Contact Us
Filters
Showing results (441-450 of 481) with videos related to
Page
of 49
Sort By:
Public Health Reports (Washington, D.C. : 1974)
|
May 4, 2010
Hyperendemic H. pylori and tapeworm infections in a U.S.-Mexico border population
Victor M Cardenas, Kristina D Mena, Melchor Ortiz, et al.
Human Pathology
|
December 3, 2014
Differences in interleukin 8 expression in Helicobacter pylori-infected gastric mucosa tissues from patients in Bhutan and the Dominican Republic
Hiroyuki Nagashima, Shun Iwatani, Modesto Cruz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 3, 2018
Equivalent Efficacies of Reverse Hybrid and Bismuth Quadruple Therapies in Eradication of Helicobacter pylori Infection in a Randomized Controlled Trial
Ping-I Hsu, Feng-Woei Tsay, David Y Graham, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 11, 2012
Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men
Jennifer R Kramer, Lori A Fischbach, Peter Richardson, et al.
Gut
|
February 15, 2013
Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study
Hashem B El-Serag, Ali Hashmi, Jose Garcia, et al.
Nature
|
February 9, 2007
An African origin for the intimate association between humans and Helicobacter pylori
Bodo Linz, François Balloux, Yoshan Moodley, et al.
Alimentary Pharmacology & Therapeutics
|
April 26, 2019
Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment
Qi Chen, Xiaohua Long, Yingjie Ji, et al.
The Lancet. Gastroenterology & Hepatology
|
July 26, 2018
Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1/2 study
Peter Malfertheiner, Michael Selgrad, Thomas Wex, et al.
Journal of Clinical Microbiology
|
August 7, 2004
Alanine-threonine polymorphism of Helicobacter pylori RpoB is correlated with differential induction of interleukin-8 in MKN45 cells
Keun-Hwa Lee, Myung-Je Cho, Yoshio Yamaoka, et al.
Antibiotics (Basel, Switzerland)
|
August 29, 2024
Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn's Disease
David Y Graham, Saleh A Naser, Thomas Borody, et al.
Page
of 49
Search research articles
Search
Showing results (441-450 of 481) with videos related to
Sort By:
Page
of 49
Public Health Reports (Washington, D.C. : 1974)
|
May 4, 2010
Hyperendemic H. pylori and tapeworm infections in a U.S.-Mexico border population
Victor M Cardenas, Kristina D Mena, Melchor Ortiz, et al.
Human Pathology
|
December 3, 2014
Differences in interleukin 8 expression in Helicobacter pylori-infected gastric mucosa tissues from patients in Bhutan and the Dominican Republic
Hiroyuki Nagashima, Shun Iwatani, Modesto Cruz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 3, 2018
Equivalent Efficacies of Reverse Hybrid and Bismuth Quadruple Therapies in Eradication of Helicobacter pylori Infection in a Randomized Controlled Trial
Ping-I Hsu, Feng-Woei Tsay, David Y Graham, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 11, 2012
Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men
Jennifer R Kramer, Lori A Fischbach, Peter Richardson, et al.
Gut
|
February 15, 2013
Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study
Hashem B El-Serag, Ali Hashmi, Jose Garcia, et al.
Nature
|
February 9, 2007
An African origin for the intimate association between humans and Helicobacter pylori
Bodo Linz, François Balloux, Yoshan Moodley, et al.
Alimentary Pharmacology & Therapeutics
|
April 26, 2019
Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment
Qi Chen, Xiaohua Long, Yingjie Ji, et al.
The Lancet. Gastroenterology & Hepatology
|
July 26, 2018
Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1/2 study
Peter Malfertheiner, Michael Selgrad, Thomas Wex, et al.
Journal of Clinical Microbiology
|
August 7, 2004
Alanine-threonine polymorphism of Helicobacter pylori RpoB is correlated with differential induction of interleukin-8 in MKN45 cells
Keun-Hwa Lee, Myung-Je Cho, Yoshio Yamaoka, et al.
Antibiotics (Basel, Switzerland)
|
August 29, 2024
Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn's Disease
David Y Graham, Saleh A Naser, Thomas Borody, et al.
Page
of 49